Note: Ingredients listed on restricted chemical lists
EC/CAS
205-483-3/141-43-5
Name of the chemical
2-aminoethanol
Concentration
≥5
EC/CAS
223-296-5/3811-73-2
Name of the chemical
Pyridine-2-thiol 1-oxide, sodium salt
Concentration
≥0.1
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
≥0.1
General Information
Version
1.0
Revision date
2023-09-18
Product name
Supergrind Ultra
1.2.1 Relevant identified uses
Industrial use,Professional use
Manufacturer Name
Morris Lubricants
Emergency telephone
+44 (0) 1743 232200
Icons in SDS
Company Information
company name
Morris Lubricants
e-mail address of the competent person responsible for the Safety Data Sheet
sds@morris-lubricants.co.uk
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H335, H400
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Causes skin irritation. May cause an allergic skin reaction. Causes serious eye damage.
2.2 Label elements
Labelling
Hazard pictograms
GHS07 GHS09
Signal word
Warning
Contains
2-aminoethanol; 1,2-benzisothiazol-3(2H)-one; 2-methylpentane-1,5-diamine
Hazard statements
H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H335 - May cause respiratory irritation. H400 - Very toxic to aquatic life.
Precautionary statements
P273 - Avoid release to the environment. P280 - Wear protective clothing, eye protection, face protection. P303+P361+P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water or shower.
Supplemental label elements
EUH070 - Toxic by eye contact.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
